Cancer Clinical Trial - InhibRx INBRX-105

CONDITIONS(S): Advanced Solid Tumors, Melanoma - TRIAL:An Open-Label, Multicenter, First-in-Human, Dose-Escalation, Phase 1 Study of INBRX-105 in Patients With Locally Advanced or Metastatic Solid Tumors

Drug

INBRX-105

Trial Type

Treatment

Phase

Phase 1

Condition

Advanced solid tumors Melanoma

Keywords

Advanced solid tumors | InhibRx | Melanoma